Skip to content
Home/Companies/Biotech/Quell Therapeutics
QT

Quell Therapeutics

Biotech·United Kingdom·Active·5yr hold

Quell Therapeutics is a biotech company, headquartered in United Kingdom.

Entry
2021
Hold
5yr
Status
Active
Est. EV
–

Who owns Quell Therapeutics?

Quell Therapeutics is currently owned by Jeito Capital through Jeito I (2021 vintage), since 2021. Across its history, Quell Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-05-13

Jeito Capital
Most recent investor
Jeito Capital
Jeito I · 2021 · VC
2 ownership periods · full history below

Key facts

HQUnited Kingdom
SectorBiotech
StatusActive

Ownership history

2 ownership periods · co-invest detected

Active
Co-held by SV Health Managers and Jeito Capital since 2021.
Co-invest · 2 holders · 2021 · present
SV Health Managers
SV Health ManagersActive
2021 · present · SV7 Impact Medicine Fund · 2019 · Life Sciences VC
MOIC
–
Jeito Capital
Jeito CapitalActive
2021 · present · Jeito I · 2021 · VC
MOIC
–

More from Jeito I

Other portfolio companies in the same fund.

Corteria Pharmaceuticals
Active
BiotechFrance· 2023
Noema Pharma
Active
BiotechSwitzerland· 2023
Advesya
Active
BiotechSpain· 2022
CatalYm
Active
BiotechGermany· 2022
CDR-Life
Active
BiotechSwitzerland· 2022
EyeBio
Exited 2024
BiotechUS· 2022
to

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings